Tuesday, June 2, 2009
"After paying out almost $5 billion in the US, Merck is defending a class action in Australia where a journal that never was came to light. Meanwhile in the UK victims see no prospect of compensation - writes Prof. Peter Saunders"
There are about 10,000 people in the United Kingdom who believe they are due compensation for damages they suffered while on Merck's Vioxx. These persons cannot get legal aid and if they lose they will have to pay Merck’s costs. Merck has deep pockets so the company has effectively been handed a default victory by the British government. However, in Australia, 1000 Vioxx users are bringing a class action to trial, and the outcome there may be quite different.